Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

ihl

  • Home
  •  
  • ihl



  • Most Read
  • Latest Comments
  • Incannex to launch psychedelic-assisted clinics across Australia
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Incannex to launch psychedelic-assisted clinics across Australia
    • News

    AV uptake leads Audinate to push European expansion through recruiting drive
    Public
  • Incannex to launch psychedelic-assisted clinics across Australia
    • Opinion

    What the SportsBet-BetEasy merger means for TabCorp and punters
    Public
  • Incannex to launch psychedelic-assisted clinics across Australia
    • News

    Why this Tasmanian whisky brand had a record sales quarter
    Public
  • Incannex to launch psychedelic-assisted clinics across Australia
    Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • Tryptamine Therapeutics’ psilocybin trials deliver pain relief to all patients
    Tryptamine Therapeutics' psilocybin trials deliver pain relief to all patients
    • News

  • Vitura’s Cortexa becomes first Aus company to supply ecstasy and magic mushrooms under TGA’s prescriber scheme
    Vitura’s Cortexa becomes first Aus company to supply ecstasy and magic mushrooms under TGA’s prescriber scheme
    • News

  • Melodiol reports positive results from Halucenex trials for magic mushrooms to treat PTSD
    Melodiol reports positive results from Halucenex trials for magic mushrooms to treat PTSD
    • News

  • Incannex set to start psychedelic-assisted PTSD treatment in September after TGA approval
    Incannex set to start psychedelic-assisted PTSD treatment in September after TGA approval
    • News

  • Emyria recruits first patient for its meth-assisted therapy to treat PTSD
    Emyria recruits first patient for its meth-assisted therapy to treat PTSD
    • News

  • Incannex to launch psychedelic-assisted clinics across Australia
    • News

    Incannex to launch psychedelic-assisted clinics across Australia

    In February 2023, Australia became the first country to accept psychedelics, i.e. hallucinogenic drugs, as medicine. It approved the use of MDMA and psilocybin, typically known as mushrooms and ecstasy, for psychiatric help.  Medical cannabis and psychedelics manufacturer Incannex Healthcare (ASX: IHL) wasted no time and announced the launch of the first psychedelic-assisted psychotherapy clinic.

    Read More
    Public
  • How Incannex is helping you catch some zzz’s
    • News

    How Incannex is helping you catch some zzz’s

    Unsurprisingly, four out of ten adults experience regular poor sleep. We all know the consequences of a bad night’s rest on our health, performance and mood, as well as the crippling caffeine addiction that develops. *Sips double shot oat milk latte*  People with Obstructive Sleep Apnoea (OSA) have it worse. OSA is characterised by partial

    Read More
    Public
  • Incannex to launch world-first Magic Mushroom trials to treat anxiety
    • News

    Incannex to launch world-first Magic Mushroom trials to treat anxiety

    Throughout the 1950s, psychotherapy was a form of treatment for mental disorders from limited research but with the world having undertaken medical breakthroughs since, pharmaceuticals company Incannex Healthcare (ASX: IHL) is re-visiting the use of psilocybin as a treatment for anxiety through clinical trials in partnership with Monash University. Psilocybin is better known as magic

    Read More
    Public

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.